Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

  title={Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient},
  author={Alexander Howard Peden and Mark W Head and L Ritchie Diane and E. Jeanne and W Ironside James},
  journal={The Lancet},

Figures and Tables from this paper

Variant Creutzfeldt-Jakob disease: an update.

The recent report of a blood test that may be used to detect vCJD has raised the possibility of a new way to identify infected individuals, perhaps even before the onset of clinical symptoms.

Risk of Transmission of Creutzfeldt–Jakob Disease by Blood Transfusion

The experimental evidence for the transmission of prion infectivity by blood transfusion in a range of experimental models is reviewed and the future possibilities for the development and potential uses of blood-based screening tests for human prion diseases are considered.

Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia

Estimates of the relative risks of exposure through diet, surgery, endoscopy, blood transfusion and receipt of UK‐sourced plasma products suggest that by far the most likely route of infection in this patient was receipt ofUK plasma products.

Variant Creutzfeldt–Jakob disease: risk of transmission by blood transfusion and blood therapies

  • J. Ironside
  • Medicine
    Haemophilia : the official journal of the World Federation of Hemophilia
  • 2006
There remains a distinct possibility that some infected patients may never develop clinical symptoms but will remain asymptomatic carriers who can potentially transmit the disease to other individuals, so screening of infectious individuals will be a critical component for individuals who rely on blood transfusions and/or blood therapies.

Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt–Jakob disease

It is demonstrated that spleen tissue from a PRNP MV genotype individual can propagate the variant Creutzfeldt–Jakob disease agent and that the infectious agent can be present in the spleen without CNS involvement.

Preclinical Detection of Variant CJD and BSE Prions in Blood

Results indicate that the homology of PrP amino-acid sequence between the seed and the substrate is not the crucial determinant of the vCJD agent propagation in vitro, and the ovine Q171 PrP substrates provided the best amplification performances.

Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.

This case illustrates the importance of molecular analysis of prion disease, including the use of EDTA to investigate the metal dependence of protease cleavage patterns of PrP(Sc).

Edinburgh Research Explorer Variant Creutzfeldt-Jakob disease

  • Medicine
  • 2018
This is the first indication that the valine homozygous subgroup at codon 129 in the PRNP is susceptible to vCJD infection.



Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease.

Using sensitive techniques, extraneural deposition of PrPSc is identified in spleen and muscle samples from approximately one third of patients who died with sporadic Creutzfeldt-Jakob disease, and appears to correlate with a long duration of disease.

Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt–Jakob disease

Lymphoreticular accumulation of PrP appears to be a highly specific feature of variant Creutzfeldt–Jakob disease, as assessed by immunocytochemistry.

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples

The findings reinforce the importance of measures taken by the UK Department of Health to reduce the risk of spread of variant Creutzfeldt‐Jakob via blood products and surgical instruments, and of the urgency to proceed with large‐scale screening of fresh tonsil specimens for the presence of prion protein.